-
Posted: September 29th, 2010, 8:00am CDT
High C-reactive protein levels have been linked to a higher risk for heart disease, and levels vary according to people's ancestry, researchers have revealed in a study published in the American Heart Association journal Circulation: Cardiovascular Genetics. The authors explain that how doctors determine statin treatment may be impacted by patients' C-reactive protein values...
-
Posted: September 29th, 2010, 5:00am CDT
Average C-reactive protein (CRP) values vary in diverse populations - possibly impacting how doctors estimate cardiovascular risk and determine statin treatment, according to a new study in Circulation: Cardiovascular Genetics, a journal of the American Heart Association...
-
Posted: September 24th, 2010, 7:00am CDT
Children's Hospital & Research Center Oakland announced today that the US Food and Drug Administration (FDA) has granted clearance of an Investigational New Drug (IND) application to introduce Trappsol® Cyclo™ (Hydroxypropyl Beta Cyclodextrin or HPBCD) into the brains of six year old identical twin girls dying of a rare brain-destroying cholesterol disease called Niem...
-
Posted: September 24th, 2010, 6:00am CDT
To understand the health effects of high cholesterol levels, doctors first need to assess malnutrition and inflammation status in their chronic kidney disease (CKD) patients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). Patients with CKD often develop and die from cardiovascular disease (CVD)...
-
Posted: September 22nd, 2010, 2:00am CDT
A drug commonly prescribed for people with high cholesterol may also be effective in treating prostate cancer, according to new research by Dr. Xiao-Yan Wen at St. Michael's Hospital. Rosuvastatin - a statin drug sold as Crestor - suppressed the growth of transplanted human prostate cancer cells in mice...
-
Posted: September 18th, 2010, 4:00am CDT
The article discusses the clinical advantages of advanced cholesterol testing in reducing cardiovascular disease (CVD) risk in patients with Type 2 diabetes and details several currently available advanced lipid tests, including the VAP® Cholesterol Test from Atherotech. Cobble also explores which patients are appropriate to test and how to apply advanced lipid testing results...
-
Posted: September 18th, 2010, 2:00am CDT
Scientists at the Southwest Foundation for Biomedical Research (SFBR) in San Antonio have found a gene that causes high levels of bad cholesterol to accumulate in the blood as a result of a high-cholesterol diet...
-
Posted: September 17th, 2010, 3:00am CDT
A gene network behind hardening of the arteries and coronary heart disease has been identified by a team of scientists from Australia, Europe and the United Kingdom. Their findings expose potential targets for the treatment of heart disease...
-
Posted: September 14th, 2010, 3:00am CDT
The most cost-effective programs for helping patients stay on cholesterol and blood pressure-lowering medications have been identified in a comprehensive research study from IMS Health...
-
Posted: September 11th, 2010, 3:00am CDT
Polycystic Ovarian Syndrome, known as PCOS, is a silent and often mysterious disease that plays havoc with a woman's body and increases the risk of serious illness. PCOS is the number one cause of female infertility and increases the risk of heart disease, insulin resistance, diabetes and certain cancers...
-
Posted: September 11th, 2010, 2:00am CDT
A method that is widely used to predict the risk of a major coronary event may over- or underestimate risk for millions of Americans, according to a study directed by a researcher at the San Francisco VA Medical Center and the University of California, San Francisco...
-
Posted: September 10th, 2010, 5:00am CDT
Millions of Americans potentially reclassified into high-risk or low-risk groups with different treatment as a result. The widespread use of a simplified clinical tool to estimate future coronary risk could lead to the classification of millions of Americans into different risk groups than when using the original, "gold-standard" tool...
-
Posted: September 9th, 2010, 6:00am CDT
In honor of Cholesterol Education Month, The American Pharmacists Association (APhA) would like to highlight the increasing role of the pharmacist in communities nationwide...
-
Posted: September 8th, 2010, 6:00am CDT
New findings reported in the September issue of Cell Metabolism, a Cell Press publication, appear to explain why people who carry specific and common versions of a single gene are more likely to have high cholesterol and to suffer a heart attack. Studies in mice show that the gene, known as sortilin (SORT1), controls the release of LDL (a.k.a...
-
Posted: September 8th, 2010, 5:00am CDT
HHS' Agency for Healthcare Research and Quality today released a series of free evidence-based guides designed to help Spanish speakers understand and compare the risks, benefits and side effects of treatments for eight health conditions. The guides provide valuable information that patients can use in talking with their clinicians...
-
Posted: September 7th, 2010, 7:00am CDT
Chemicals used in the production of non-stick cookware and waterproof fabrics, known as perfluoroalkyl acids, can get into children's blood and raise their LDL cholesterol levels ("bad cholesterol" levels), says an article published in Archives of Pediatrics & Adolescent Medicine. Examples of perfluoroalkyl acids include PFOA (perfluorooctanoic acid) and PFOS (perfluorooctanesulfonate)...
-
Posted: September 1st, 2010, 8:00am CDT
Genzyme Corp. (NASDAQ: GENZ) and Isis Pharmaceuticals Inc. (NASDAQ: ISIS) announced that data from the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) were presented at the European Society of Cardiology's Congress 2010 in Stockholm, Sweden...
-
Posted: September 1st, 2010, 2:00am CDT
Research conducted in the Netherlands has highlighted the need for care when switching patients under treatment for high cholesterol from branded to generic drug families. The study shows that much of the switching can result in patients inadvertently receiving non-equivalent doses, potentially leading to an increased risk of downstream heart disease and stroke...